Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

GSK scientists identify new B-Raf kinase inhibitors

Jan. 10, 2003

CA4P enters new phase I/II trial in advanced cancers

Jan. 10, 2003

New TNF-alpha production inhibitors discovered by Celgene

Jan. 9, 2003

Panacea extends collaboration for HAAH oncology program

Jan. 9, 2003

European approval received for use of Glivec as first-line treatment in CML

Jan. 9, 2003

Leo claims guanidine-based IKK inhibitors for cancer and inflammatory disorders

Jan. 8, 2003

Sosei obtains Japanese rights to Eligard

Jan. 8, 2003

Manufacturing and supply agreement signed for Genasense

Jan. 8, 2003

Pharmacokinetic, toxicity and efficacy data for LEraf-AON in animals

Jan. 7, 2003

HDAC inhibitor MS-275 active against pediatric solid tumors in vitro and in vivo

Jan. 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...